MICHAEL FRUMOVITZ to Adenocarcinoma, Mucinous
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about Adenocarcinoma, Mucinous.
Connection Strength
1.686
-
Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma. Obstet Gynecol. 2019 12; 134(6):1253-1259.
Score: 0.531
-
Mucinous tumors of the ovary: current thoughts on diagnosis and management. Curr Oncol Rep. 2014 Jun; 16(6):389.
Score: 0.363
-
Unmasking the complexities of mucinous ovarian carcinoma. Gynecol Oncol. 2010 Jun; 117(3):491-6.
Score: 0.271
-
Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer. Obstet Gynecol. 2023 05 01; 141(5):1019-1023.
Score: 0.167
-
PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer. Mol Cancer Ther. 2019 01; 18(1):162-172.
Score: 0.123
-
Targeting SRC and tubulin in mucinous ovarian carcinoma. Clin Cancer Res. 2013 Dec 01; 19(23):6532-43.
Score: 0.087
-
Targeting SRC in mucinous ovarian carcinoma. Clin Cancer Res. 2011 Aug 15; 17(16):5367-78.
Score: 0.074
-
Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary. Obstet Gynecol. 2010 Aug; 116(2 Pt 1):269-273.
Score: 0.070